CLINICAL_TRIALS
trial_result
· 2017-02-28
Clinical Trial Update: Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma [Phase 3]
Summary
A Phase 3 trial comparing eribulin with dacarbazine in soft tissue sarcoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Inc. | Conditions: Soft Tissue Sarcoma | Phase 3 | Status: COMPLETED | Results posted: 2017-02-28